San Diego, CA, United States of America

Jeffrey M Smith

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 2.7

ph-index = 8

Forward Citations = 266(Granted Patents)


Company Filing History:


Years Active: 2005-2022

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey M. Smith

Introduction

Jeffrey M. Smith is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, he has made remarkable advancements in the treatment of various medical conditions.

Latest Patents

Among his latest patents are the development of 1,2,4-oxadiazole derivatives as liver X receptor agonists. This invention provides compounds and pharmaceutical compositions that are useful for treating meibomian gland dysfunction (MGD). The compounds can be administered to a subject in need of a therapeutically effective amount. Another notable patent involves 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases. This invention includes a method for manufacturing the compounds and outlines their therapeutic uses, along with a combination of pharmacologically active agents.

Career Highlights

Throughout his career, Jeffrey has worked with notable companies such as Arena Pharmaceuticals, Inc. and Novartis AG. His work in these organizations has contributed to the development of innovative treatments and has solidified his reputation as a leading inventor in the pharmaceutical industry.

Collaborations

Jeffrey has collaborated with several talented individuals, including Brian Christopher Smith and Valentina Molteni. These partnerships have fostered a creative environment that has led to the successful development of his patented inventions.

Conclusion

In summary, Jeffrey M. Smith's innovative work and numerous patents have significantly impacted the pharmaceutical field. His dedication to advancing medical treatments continues to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…